Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7246 p563-567
26 April 2003

News summary

DIARY   Branch meetings   Future Events   Conferences

563 Better partnerships predicted between pharmacists and family doctors New partnerships between community pharmacists and general practitioners will be developed in coming years. The trend will be driven by a number of factors, including the new GP contract. This is the conclusion of a report by Professor David Taylor and colleagues at the department of practice and policy, School of Pharmacy, University of London ...[more]

563 Cholesterol inhibitor launched as additional treatment to statins Ezetimibe (Ezetrol), a cholesterol absorption inhibitor, has been launched this week by Merck Sharpe & Dohme and Schering Plough...[more]

563 Improved access to pharmacists will help reduce ADEs As much as a third of adverse drug events (ADEs) that occur in primary care are preventable or could be ameliorated, say American researchers. Furthermore, improving access to pharmacists would help reduce ADE frequency...[more]

564 Capacity of NHS Direct will more than double over the next three years NHS Direct is to be significantly expanded over the next three years. The plan is outlined in a new strategy document "Developing NHS Direct" launched by Health Minister John Hutton on 15 April...[more]

564 Department of Health sponsors complementary medicine research Over £1.3m is to be spent by the Department of Health this year on research into complementary treatments and alternative medicine...[more]

564 Moss wins new prison contract Moss Pharmacy has won a contract to supply pharmaceutical services to Her Majesty's Prison Everthorpe...[more]

564 NiQuitin supports Formula One In a turnaround for motor racing, the BMW Williams Formula One team is to be sponsored by NiQuitin CQ...[more]

564 Pfizer-Pharmacia merger finalised The merger between the pharmaceutical companies Pfizer and Pharmacia became effective on 16 April...[more]

564 PSC work programme The Pharmacy Sector Committee has set out its work programme for this year...[more]

565 Drug companies win Queen's Awards Pharmaceutical companies are among the winners of this year's Queen's Awards for Enterprise...[more]

565 Pharmacy plan for Northern Ireland The Northern Ireland Department of Health, Social Services and Public Safety has published a consultative community pharmacy strategy which sees potential for pharmacists to provide an open door to the health service...[more]

565 Largest UK healthy living centre opened The United Kingdom's largest healthy living centre, the Sunlight Centre, was opened on 16 April...[more]

566 DTB discounts MMR and autism link There is no convincing evidence that the measles, mumps and rubella vaccine causes autism or inflammatory bowel disease, according to a review in the Drug and Therapeutics Bulletin...[more]

566 Remind patients with glaucoma of importance of using eye-drops Patients with primary open angle glaucoma need to understand the importance of using their eye-drops regularly, the latest MeReC Bulletin says...[more]

566 A new vitamin B? Researchers from Japan have discovered a pyrroloquinoline quinone (PQQ) dependent enzyme that enables mice to break down the amino acid lysine...[more]

566 Gap in asthma knowledge A persistent night-time cough is not widely recognised as a common symptom of asthma, a new survey suggests...[more]

566 Supplements promote weight loss There is evidence that ephedrine and ephedra promote short-term weight loss in clinical trials, say researchers. However, there are no data on long-term weight loss, and evidence to support the use of ephedra, also known as ma huang, to enhance athletic performance is insufficient...[more]

567 Canvassing breaks Council agreement Canvassing on behalf of a group of seven candidates in the Royal Pharmaceutical Society's Council election has been taking place on the Private-Rx internet website...[more]

567 New WHO advice on SARS The World Health Organization has extended its travel advice to include Beijing and the Shanxi Province, China, and Toronto, Canada...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal